NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000052804

Registered date:01/12/2023

Mitochondrial preemptive medicine

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedParkinson's disease, Alzheimer's disease, depression, cancer, hearing loss, inflammatory bowel disease, ALS and other neurological disorders, hypertension, diabetes, renal disease
Date of first enrollment2021/05/26
Target sample size6284
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeWe will analyze the clinical data of the patients and basic information of the healthy subjects, whole genome analysis, epigenome analysis, transcriptome analysis, metabolome analysis of various metabolites, fecal culture and metagenome analysis, metatranscriptome analysis, and proteome analysis of the collected specimens.
Secondary OutcomePatient and healthy subject data will be compared with Tohoku Medical Megabank Organization data (three-generation cohort and enterobacterial cohort).

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients will be excluded from the study if consent from the patient or the patient's family cannot be obtained.

Related Information

Contact

public contact
Name Takaaki Abe
Address 1-1 Seiryo-machi, Aoba-Ward, Sendai, Miyagi, Japan Japan 980-8574
Telephone 022-717-7200
E-mail mitomoonshot@med.tohoku.ac.jp
Affiliation Tohoku Univerisity, Graduate School of Biobedical Engineering Division of Medical Science
scientific contact
Name Takaaki Abe
Address 1-1 Seiryo-machi, Aoba-Ward, Sendai, Miyagi, Japan Japan
Telephone 022-717-7200
E-mail mitomoonshot@med.tohoku.ac.jp
Affiliation Tohoku Univerisity, Graduate School of Biobedical Engineering Division of Medical Science